The answer to that is best served up hot by the li
Post# of 148126
Personally I would like to see the HIV anti-inflammatory study fast tracked while looking at partnerships for other indications like MASH or cancer that will require large, expensive and time protracted investments to results. The HIV study is quick and should easily suggest a Broadway hit for a multitude of clinical indications. Getting out of the current tar-pit requires a bit of three-dimensional game theory…I am convinced Dr. J see’s the road ahead and has all the moves mapped out.